GOV.UK

Landmark UK-US pharmaceuticals deal to safeguard medicines access and drive vital investment for UK patients and businesses

Newsmax

1236577

BBC News

US and UK agree zero tariffs deal on pharmaceuticals

The Telegraph

Trump Spare Uk Drugs Tariffs After Nhs Agrees Pay More

AJBell

US to zero out tariffs on UK pharmaceuticals under trade deal

Metaculus

Drugs approved by FDA in 2035

Daily Mail

Brits face paying 3bn MORE for medicines in deal to escape Donald Trump's tariffs on pharmaceutical exports

New York Post

Trump admin strikes zero tariff pharmaceutical deal with Britain  a move welcomed by drugmakers

The Pharmacist

Landmark deal between the UK and US will expand medicine access for thousands

Office of the US Trade Representative

U.S. Government Announces Agreement in Principle with the United Kingdom on Pharmaceutical Pricing

The Standard

UK and US agree zero tariff deal on pharmaceuticals

The New York Times

Us Uk Pharma Tariffs Prices.Html

ITV News

Uk And Us Agree Zero Tariff Trade Deal On Medicines

Cnbctv18

US, UK announce deal on pharmaceutical tariffs, drug pricing

The Times

Patients promised groundbreaking new drugs on NHS in deal with US

The Washington Post

6E6A66D8 Ced1 11F0 92Cb 561Ee4E6A771_Story.Html

The Hill

5628347 Trump Tariffs Uk Trade Deal Drugs

Alexandria Ocasio-Cortez

The Economist

Nick Marro

Michael Snipes

Karl Schamotta

Robert Handfield

Peterson Institute for International Economics

Arun Sundaram

Alan Siger

National Retail Federation

Gabe Horwitz

Monica Morlacco

Mary Lovely

Felix Tintelnot

Scott Harris

Stephen Tapp

Ed Brzytwa

Michael Clemens

Rachel Friedberg

Steve Hanke

John A. Konrad V

Laurence Ales

Joe Rodriguez

Jean-Baptiste Wautier

"The prices of electronics would definitely go up."

The tariffs will "increase prices for everything that's imported, and that includes food."

Trump tariffs would "raise prices even more for consumers."

"I am extremely confident that food will get more expensive."

Trump's tariffs would "increase the cost of US manufacturing."

"Trump is about to make every American pay even more for coffee."

"Tariffs would disrupt supply chains and increase production costs."

Will the Proposed Trump Tariffs Increase the Price of Groceries/Goods/Services?

The UK secured a 0% tariff rate for all pharmaceutical exports to the U.S. for at least three years, which the British government described as the lowest rate offered to any country.

The UK secured a 0% tariff rate for all pharmaceutical exports to the U.S. for at least three years, which the British government described as the lowest rate offered to any country.

In exchange for the tariff exemption, the UK committed to increasing the net price it pays for new medicines by 25%, raising the cost-effectiveness threshold from £20,000-30,000 per quality-adjusted life year to £25,000-35,000.

In exchange for the tariff exemption, the UK committed to increasing the net price it pays for new medicines by 25%, raising the cost-effectiveness threshold from £20,000-30,000 per quality-adjusted life year to £25,000-35,000.

The UK will cut the repayment rate owed by drugmakers under the Voluntary Scheme for Branded Medicines Pricing, Access, and Growth to 15% in 2026, down from around 23%, according to both official statements and sources.

The UK will cut the repayment rate owed by drugmakers under the Voluntary Scheme for Branded Medicines Pricing, Access, and Growth to 15% in 2026, down from around 23%, according to both official statements and sources.

U.S. officials stated that the deal addresses long-standing imbalances in pharmaceutical trade, with Ambassador Jamieson Greer noting that U.S patients were "forced to subsidize prescription drugs in other developed countries."

U.S. officials stated that the deal addresses long-standing imbalances in pharmaceutical trade, with Ambassador Jamieson Greer noting that U.S patients were "forced to subsidize prescription drugs in other developed countries."

Major firms like Bristol Myers Squibb announced plans to invest upwards of $500 million over five years in the UK across R&amp;D and manufacturing, while concerns were raised about firms like AstraZeneca pausing UK investments.

Major firms like Bristol Myers Squibb announced plans to invest upwards of $500 million over five years in the UK across R&D and manufacturing, while concerns were raised about firms like AstraZeneca pausing UK investments.

The Association of the British Pharmaceutical Industry said the deal could improve the UK's position to attract global life science investment. Top drugmakers had earlier criticized the drug-pricing system the UK used to control costs.

The Association of the British Pharmaceutical Industry said the deal could improve the UK's position to attract global life science investment. Top drugmakers had earlier criticized the drug-pricing system the UK used to control costs.

GOV.UK #

Newsmax #

BBC News #

The Telegraph #

AJBell #

Metaculus #

Daily Mail #

New York Post #

The Pharmacist #

Office of the US Trade Representative #

The Standard #

The New York Times #

ITV News #

Cnbctv18 #

The Times #

The Washington Post #

The Hill #

The UK secured a 0% tariff rate for all UK pharmaceutical exports to the US for at least three years, which the UK government described as the lowest rate offered to any country, while the US agreed to exempt UK-origin pharmaceuticals and medical technology from tariffs.

The UK secured a 0% tariff rate for all UK pharmaceutical exports to the US for at least three years, which the UK government described as the lowest rate offered to any country, while the US agreed to exempt UK-origin pharmaceuticals and medical technology from tariffs.

In exchange for the tariff exemption, the UK committed to increase the net price it pays for new medicines by 25%, raising the cost-effectiveness threshold from 20,000 to 30,000 pounds per quality-adjusted life year to 25,000 to 35,000 pounds per quality-adjusted life year.

In exchange for the tariff exemption, the UK committed to increase the net price it pays for new medicines by 25%, raising the cost-effectiveness threshold from 20,000 to 30,000 pounds per quality-adjusted life year to 25,000 to 35,000 pounds per quality-adjusted life year.

The UK will reduce the repayment rate owed by pharmaceutical companies under the Voluntary Scheme for Branded Medicines Pricing, Access and Growth to 15% in 2026, down from approximately 23%, according to statements from both governments and industry sources.

The UK will reduce the repayment rate owed by pharmaceutical companies under the Voluntary Scheme for Branded Medicines Pricing, Access and Growth to 15% in 2026, down from approximately 23%, according to statements from both governments and industry sources.

US officials stated that the agreement addresses long-standing imbalances in pharmaceutical trade, with Ambassador Greer noting that American patients have been forced to subsidize prescription drugs in other developed countries by paying a significant premium for the same products.

US officials stated that the agreement addresses long-standing imbalances in pharmaceutical trade, with Ambassador Greer noting that American patients have been forced to subsidize prescription drugs in other developed countries by paying a significant premium for the same products.

Major pharmaceutical companies including Bristol Myers Squibb announced plans to invest upwards of $500 million over five years in the UK across research, development and manufacturing, while concerns had been raised about firms like AstraZeneca canceling or pausing UK investments.

Major pharmaceutical companies including Bristol Myers Squibb announced plans to invest upwards of $500 million over five years in the UK across research, development and manufacturing, while concerns had been raised about firms like AstraZeneca canceling or pausing UK investments.

The Association of the British Pharmaceutical Industry described the deal as an important step toward ensuring patient access to innovative medicines and improving the UK's position to attract global life science investment, though noting many details remain to be worked out.

The Association of the British Pharmaceutical Industry described the deal as an important step toward ensuring patient access to innovative medicines and improving the UK's position to attract global life science investment, though noting many details remain to be worked out.

Britain's pharmaceutical deal with the US forces taxpayers to fork over an extra 3 billion while the NHS budget for medicines balloons from 9.5% to 12%. The agreement raises drug prices by 25% and weakens cost-effectiveness standards that previously protected patients from overpriced treatments, all to appease Trump's demands that Europe subsidize American pharmaceutical profits.

Britain's pharmaceutical deal with the US forces taxpayers to fork over an extra 3 billion while the NHS budget for medicines balloons from 9.5% to 12%. The agreement raises drug prices by 25% and weakens cost-effectiveness standards that previously protected patients from overpriced treatments, all to appease Trump's demands that Europe subsidize American pharmaceutical profits.

This landmark agreement finally ends decades of Britain freeloading off American patients who've been forced to subsidize the world's drug costs. The deal secures zero tariffs on 5 billion worth of UK pharmaceutical exports while ensuring fair pricing that will fuel innovation and bring cutting-edge treatments to patients faster.

This landmark agreement finally ends decades of Britain freeloading off American patients who've been forced to subsidize the world's drug costs. The deal secures zero tariffs on 5 billion worth of UK pharmaceutical exports while ensuring fair pricing that will fuel innovation and bring cutting-edge treatments to patients faster.

UK Secures Zero Tariffs on US Pharma Exports in Trade Deal

Medicine & healthcare

Pharmaceuticals

United Kingdom

United States of America

The U.S.-UK deal forces taxpayers to pay an extra £3 billion while the NHS budget for medicines balloons from 9.5% to 12%. It raises drug prices by 25% and weakens cost-effectiveness standards that protected patients from overpriced treatments, all to appease Trump's demand that Europe subsidize U.S. pharmaceutical profits.

The U.S.-UK deal forces taxpayers to pay an extra £3 billion while the NHS budget for medicines balloons from 9.5% to 12%. It raises drug prices by 25% and weakens cost-effectiveness standards that protected patients from overpriced treatments, all to appease Trump's demand that Europe subsidize U.S. pharmaceutical profits.

This landmark agreement finally ends decades of Britain freeloading off American patients who've been forced to subsidize the world's drug costs. The deal secures zero tariffs on £5 billion worth of UK pharmaceutical exports while ensuring fair pricing that will fuel innovation and bring cutting-edge treatments to patients.

This landmark agreement finally ends decades of Britain freeloading off American patients who've been forced to subsidize the world's drug costs. The deal secures zero tariffs on £5 billion worth of UK pharmaceutical exports while ensuring fair pricing that will fuel innovation and bring cutting-edge treatments to patients.

There is a 50% chance 69.7 drugs will be approved by the FDA in 2035, according to the Metaculus prediction community.

There is a 50% chance 69.7 drugs will be approved by the FDA in 2035, according to the Metaculus prediction community.

Matt Cardy/Getty Images

Matt Cardy/Getty Images

UK Secures Zero Tariffs on US Pharma Exports in Trade Deal

UK Secures Zero Tariffs on US Pharma Exports in Trade Deal

The Spin

Metaculus Prediction

The Controversies

Handfield

Snipes

Tapp

Friedberg

Hanke

Ocasio-Cortez

Wautier

Articles on this story

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

UK Secures Zero Tariffs on US Pharma Exports in Trade Deal

UK Secures Zero Tariffs on US Pharma Exports in Trade Deal

The Spin

Metaculus Prediction

The Controversies

Handfield

Snipes

Tapp

Friedberg

Hanke

Ocasio-Cortez

Wautier

Articles on this story

Sign Up for Our Free NewslettersSign Up for Our Free Newsletters

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters